Management of hyperlipidemia of kidney disease.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Kidney International

• Publication date

  1990-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/KI.1990.57PMID 2179614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum lipid and lipoprotein concentrations in chronic uremia.

  2009cited by this paper
• Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.

  2009cited by this paper
• Hypertriglyceridemia.

  2006cited by this paper
• Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.

  2004cited by this paper
• A survey of vascular access for haemodialysis in The Netherlands.

  1991cited by this paper
• Influence of plasma triglycerides on lipoprotein patterns in normal subjects and in patients with coronary artery disease.

  1989cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria.

  1989cited by this paper
• Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.

  1988cited by this paper
• HMG-CoA reductase inhibitors for treatment of hypercholesterolemia.

  1988cited by this paper
• Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation.

  1988cited by this paper
• Hypertriglyceridemia: Causes and Relation to Coronary Heart Disease

  1988cited by this paper
• Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome.

  1988cited by this paper
• Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism.

  1988cited by this paper
• Low-density lipoprotein subclass patterns and risk of myocardial infarction.

  1988cited by this paper
• Normalization of lipoprotein lipase and hepatic lipase by gemfibrozil results in correction of lipoprotein abnormalities in chronic renal failure.

  1987cited by this paper
• Albumin synthesis, albuminuria and hyperlipemia in nephrotic patients.

  1987cited by this paper
• Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol.

  1987cited by this paper
• Decreased VLDL apoprotein CII/apoprotein CIII ratio may be seen in both normotriglyceridemic and hypertriglyceridemic patients on chronic hemodialysis treatment.

  1987cited by this paper
• Persistent Hyperlipidemia in Renal Transplant Patients

  1987cited by this paper
• Effect of probucol on hyperlipidemia in patients with nephrotic syndrome.

  1987cited by this paper
• Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men.

  1987cited by this paper
• Serum apolipoprotein profile of patients with chronic renal failure.

  1987cited by this paper
• Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

  1987cited by this paper
• Fibric acids: effects on lipids and lipoprotein metabolism.

  1987cited by this paper
• Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

  1987cited by this paper
• Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease.

  1987cited by this paper
• Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits.

  1986cited by this paper
• Cholesterol and coronary heart disease. A new era.

  1986cited by this paper
• Lipid lowering treatment with bezafibrate in patients on chronic haemodialysis: Pharmacokinetics and effects

  1986cited by this paper
• Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

  1986cited by this paper
• Probucol inhibits oxidative modification of low density lipoprotein.

  1986cited by this paper
• Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients.

  1986cited by this paper
• Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial.

  1986cited by this paper
• A new challenge for America: the National Cholesterol Education Program.

  1986cited by this paper
• Hyperlipidemia after renal transplantation in children on alternate day corticosteroid therapy.

  1986cited by this paper
• Influence of combined therapy with mevinolin and interruption of bile-acid reabsorption on low density lipoproteins in heterozygous familial hypercholesterolemia.

  1985cited by this paper
• Lipoprotein predictors of the severity of coronary artery disease in men and women.

  1985cited by this paper
• Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia.

  1985cited by this paper
• Should hyperlipemia of renal failure be treated?

  1985cited by this paper
• Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan.

  1984cited by this paper
• Influence of probucol on cholesterol and lipoprotein metabolism in man.

  1984cited by this paper
• Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients.

  1984cited by this paper
• Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome.

  1984cited by this paper
• The effect of renal transplantation with a minimal steroid regime on uraemic hypertriglyceridaemia.

  1984cited by this paper
• Lipoprotein metabolism in experimental nephrosis.

  1984cited by this paper
• Patient profile and effect of dietary therapy on post-transplant hyperlipidemia.

  1983cited by this paper
• Increased lipoprotein-remnant formation in chronic renal failure.

  1982cited by this paper
• Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study.

  1982cited by this paper
• Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease.

  1982cited by this paper
• Plasma lipid alterations in patients with chronic renal disease.

  1982cited by this paper
• Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.

  1981cited by this paper
• Intermediate‐density Lipoprotein and Cholesterol‐rich Very Low Density Lipoprotein in Angiographically Determined Coronary Artery Disease

  1981cited by this paper
• The nephrotic syndrome and ischaemic heart disease.

  1981cited by this paper
• Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.

  1981cited by this paper
• Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man.

  1981cited by this paper
• Lipid abnormalities in uremia, dialysis, and transplantation.

  1981cited by this paper
• The role of diet in the pathogenesis and control of hyperlipidemia after renal transplantation.

  1981cited by this paper
• Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease.

  1980cited by this paper
• LIPOPROTEIN METABOLISM IN NEPHROTIC SYNDROME IN CHILDHOOD

  1980cited by this paper
• Separation of a lipoprotein lipase cofactor from the alpha 1-acid glycoprotein fraction from the urine of nephrotic patients.

  1980cited by this paper
• Dialysis hyperlipemia: response to dietary manipulations.

  1980cited by this paper
• Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome.

  1980cited by this paper
• Atherosclerosis in uremia: a longitudinal study.

  1980cited by this paper
• Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism.

  1980cited by this paper
• Hyperlipidaemia following renal transplantation. A study of the prevalence, 'natural history' and dietary treatment.

  1979cited by this paper
• Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis.

  1979cited by this paper
• Hyperlipidemia after renal transplantation: natural history and pathophysiology.

  1979cited by this paper
• Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.

  1979cited by this paper
• Lipoprotein lipid and protein synthesis in experimental nephrosis and plasmapheresis. I: Studies in rat in vivo

  1979cited by this paper
• Hyperlipidaemia Following Renal Transplantation

  1979cited by this paper
• Lipid disorders in renal transplant recipients.

  1978cited by this paper
• Does Pregnancy Protect Against Ovarian Cancer?

  1978cited by this paper
• Response of plasma triglycerides to dietary change in patients on hemodialysis.

  1978cited by this paper
• Hyperlipidemia in adult, pediatric and diabetic renal transplant recipients.

  1978cited by this paper
• Adipose tissue lipoprotein lipase in chronic hemodialysis: role in plasma triglyceride metabolism.

  1978cited by this paper
• Untoward effects of clofibrate in hemodialyzed patients.

  1977cited by this paper
• Reduction of plasma triglycerides by diet in subjects with chronic renal failure.

  1977cited by this paper
• Selective deficiency of hepatic triglyceride lipase in uremic patients.

  1977cited by this paper
• The low-density lipoprotein pathway and its relation to atherosclerosis.

  1977cited by this paper
• Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome

  1977cited by this paper
• Clofibrate treatment of hyperlipidemia in chronic renal failure.

  1977cited by this paper
• Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis.

  1977cited by this paper
• Chylomicron clearance in normal and hyperlipidemic man.

  1976cited by this paper
• Lipids and Lipoproteins in Chronic Uraemia. A Study of the Influence of Regular Haemodialysis **

  1976cited by this paper
• Hyperlipidemia after renal transplantation in children.

  1976cited by this paper
• Effect of acute uremia on triglyceride kinetics in the rat.

  1976cited by this paper
• Hyperlipidemia in pediatric hemodialysis and renal transplant patients. Associated with coronary artery disease.

  1976cited by this paper
• Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man.

  1976cited by this paper
• Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis.

  1976cited by this paper
• Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia.

  1975cited by this paper
• Letter: Clofibrate and gallstones.

  1975cited by this paper
• Clofibrate-induced muscle damage in patients with chronic renal failure.

  1975cited by this paper
• Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

  1975cited by this paper
• Normal serum-lipids in renal-transplant patients.

  1975cited by this paper
• CLOFIBRATE AND GALLSTONES

  1975cited by this paper
• Accelerated atherosclerosis in prolonged maintenance hemodialysis.

  1974cited by this paper
• Hyperlipidaemia after successful renal transplantation.

  1974cited by this paper
• INCREASED INCIDENCE OF CORONARY HEART DISEASE ASSOCIATED WITH COMBINED ELEVATION OF SERUM TRIGLYCERIDE AND CHOLESTEROL CONCENTRATIONS IN THE NEPHROTIC SYNDROME IN MAN

  1974cited by this paper
• Plasma Triglyceride Metabolism in the Adult Nephrotic Syndrome

  1971cited by this paper

• Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism

  2023cites this paper
• Lipids and Renal Disease.

  2019cites this paper
• Xanthomatous tendinosis.

  2012cites this paper
• Sesamin exerts renoprotective effects by enhancing NO bioactivity in renovascular hypertensive rats fed with high-fat-sucrose diet.

  2012cites this paper
• Laparoscopic Approach for Dysfunctional

  2011cites this paper
• CARACTERIZAÇÃO HEMORREOLÓGICA, BIOQUÍMICA E CARDIOVASCULAR NUM MODELO DE DOENÇA RENAL CRÓNICA MODERADA EM RATO / HEMORHEOLOGICAL, BIOCHEMICAL AND CARDIOVASCULAR CHARACTERIZATION OF A RAT MODEL OF MODERATE CHRONIC KIDNEY DISEASE

  2010cites this paper
• Endocrine and Neurologic Manifestations of Chronic Kidney Disease

  2009cites this paper
• The effectiveness of a comprehensive nutrition and exercise program on the risk for cardiovascular disease in patients with chronic kidney disease

  2009cites this paper
• Chapter 25 – Management of Complications of Nephrotic Syndrome

  2008cites this paper
• Thrombotic thrombocytopenic purpura associated with ticlopidine.

  2005cites this paper
• Lipoprotein(a)-Associated Atherothrombotic Risk in Hemodialysis Patients

  2004cites this paper
• Comparison of intermittent with continuous simvastatin treatment in hypercholesterolemic patients with end stage renal failure.

  2004cites this paper
• Upregulation of lipogenic enzymes genes expression in white adipose tissue of rats with chronic renal failure is associated with higher level of sterol regulatory element binding protein-1.

  2004cites this paper
• The Potential Role of HMG-CoA Reductase Inhibitors in Pediatric Nephrotic Syndrome

  2004cites this paper
• Lipid metabolism and secondary forms of dyslipoproteinemia in children

  2003cites this paper
• Hyperlipidemia and graft loss.

  2002cites this paper
• Low density lipoproteins and mitogenic signal transduction processes: role in the pathogenesis of renal disease.

  2002cites this paper
• Upregulation of fatty acid synthase gene expression in experimental chronic renal failure.

  2002cites this paper
• Vegetarian diet alternated with conventional low-protein diet for patients with chronic renal failure.

  2002cites this paper
• Uremic Toxicity: Present State of the Art

  2001cites this paper
• Dyslipidémies secondaires

  2001cites this paper
• Fatty acids and renal disease.

  2000cites this paper
• Rhabdomyolysis Due to Bezafibrate in Capd Patients. A Role for Dihydropyridine Drugs?

  1999cites this paper
• Management of lipid disorders.

  1999cites this paper
• Pyrazinoylguanidine in End-Stage Renal Disease: A Prospective, Placebo-Controlled Pilot Study

  1998cites this paper
• Hyperlipidemia and kidney disease: concepts derived from histopathology and cell biology of the glomerulus.

  1998cites this paper
• Chronic Renal Failure: An Overview from a Pediatric Perspective

  1998cites this paper
• Treatment of severe nephrotic syndrome.

  1998cites this paper
• Methods of literature review and synthesis.

  1998cites this paper
• Hepatic cholesterol metabolism in experimental nephrotic syndrome

  1998cites this paper
• Cardiovascular Complications in Uremia and Dialysis

  1998cites this paper
• Early elevation of lipoprotein(a) levels in chronic renal insufficiency.

  1997cites this paper
• Causes, Risks and Therapy of Hyperlipidemia in Chronic Dialysis Patients

  1997cites this paper
• Model for a One‐Step Plasma Treatment Device: Feasibility of Cholesterol Removal

  1997cites this paper
• Cardiac disease in chronic uremia: management.

  1997cites this paper
• Hyperlipidemia in dialysis patients: what treatment?

  1997cites this paper
• Optimizing end-stage renal disease therapy for the patient with diabetes mellitus.

  1997cites this paper
• Lipoprotein pattern in end‐stage renal disease and following successful renal transplantation

  1997cites this paper
• Atherogenic lipoproteins and human disease: extending concepts beyond the heart to the kidney.

  1997cites this paper
• Le Alterazioni Del Metabolismo Lipidico Nell'uremia: Dalle Fasi Precoci Della Insufficienza Renale Cronica Alla Dialisi

  1997cites this paper
• Organ and Metabolic Complications: Lipids/Atherosclerosis

  1996cites this paper
• Diabetic dyslipidemia: effects of diabetes control, diet and drug therapy.

  1996cites this paper
• Changes in clinical profile and dietary considerations after renal transplantation

  1996cites this paper
• When to treat dyslipidaemia of patients with chronic renal failure on haemodialysis? A need to define specific guidelines

  1996cites this paper
• Treatment of dyslipidemia in chronic renal failure.

  1996cites this paper
• The Hemodialysis (HEMO) Study: Rationale for Selection of Interventions

  1996cites this paper
• A low-nitrogen low-phosphorus Vegan diet for patients with chronic renal failure.

  1996cites this paper
• When to treat dyslipidaemia of patients with chronic renal failure on haemodialysis? A need to define specific guidelines.

  1996cites this paper
• Elevated Llpoprotein(A) and Fibrinogen Serum Levels Increase the Cardiovascular Risk in Continuous Ambulatory Peritoneal Dialysis Patients

  1996cites this paper
• Lipoprotein abnormalities in chronic renal failure and dialysis patients.

  1996cites this paper
• Classification of lipid disorders in chronic hemodialyzed patients.

  1996cites this paper
• Increased lipase inhibition in uremia: identification of pre-beta-HDL as a major inhibitor in normal and uremic plasma.

  1996cites this paper
• Elevated lipoprotein(a) and fibrinogen levels [corrected] increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients.

  1996cites this paper
• Hyperlipidemia in children: the role of uremia, steroids and cyclosporine therapy.

  1996cites this paper
• Pancreas transplantation: a treatment option for insulin-dependent diabetes mellitus.

  1996cites this paper
• Lipids and atherosclerosis.

  1995cites this paper
• Renal transplantation and dyslipidemia: characterization of a population and treatment with diet and low dose lovastatin.

  1995cites this paper
• Plasma lipid profile and coronary artery disease in Brazilian hemodialysis patients.

  1995cites this paper
• Lipid-lowering therapy in patients with renal disease.

  1995cites this paper
• Hyperlipoproteinemia in patients on hemodialysis and CAPD

  1995cites this paper
• Is dietary intervention effective in post-transplant hyperlipidaemia?

  1995cites this paper
• Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.

  1995cites this paper
• Hiperlipidemia en el trasplante renal. Tratamiento con pantetina

  1995cites this paper
• Consequences of pancreas transplantation.

  1994cites this paper
• Comparative mortality from cardiovascular disease in patients with chronic renal failure.

  1994cites this paper
• Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment.

  1994cites this paper
• Low-dose simvastatin is a well-tolerated and efficacious cholesterol-lowering agent in ciclosporin-treated kidney transplant recipients: double-blind, randomized, placebo-controlled study in 40 patients.

  1994cites this paper
• Lipid-lowering effect and safety of acipimox in hemodialysis patients and renal transplant recipients.

  1994cites this paper
• Gender differences in lipid alterations following combined pancreas-kidney transplantation.

  1994cites this paper
• Lipid parameters including Lp(a) in hemodialysis patients.

  1994cites this paper
• Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.

  1994cites this paper
• Secondary causes of hyperlipidemia.

  1994cites this paper
• PRAVASTATIN REDUCES SERUM CHOLESTEROL AND LOW DENSITY LIPOPROTEIN CONCENTRATIONS FOLLOWING PANCREAS TRANSPLANTATION

  1994cites this paper
• Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome.

  1994cites this paper
• Treatment of lupus nephritis: immunosuppression, general therapy, dialysis and transplantation.

  1994cites this paper
• The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation

  1993cites this paper
• Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.

  1993cites this paper
• Atherogenic lipids and lipoproteins in hemodialysis patients.

  1993cites this paper
• A review of nutrition support for transplant patients.

  1993cites this paper
• Treatment of hyperlipidemia in the nephrotic syndrome: the effects of pravastatin therapy.

  1993cites this paper
• Lipoprotein metabolism in the nephrotic syndrome.

  1993cites this paper
• Lipoprotein metabolism and renal failure.

  1993cites this paper
• Long-term efficiency, biocompatibility, and clinical safety of combined simultaneous LDL-apheresis and haemodialysis in patients with hypercholesterolaemia and end-stage renal failure.

  1993cites this paper
• Treatment of hyperlipidemia in human renal disease.

  1993cites this paper
• Relation of lipid abnormalities to progression of renal damage in essential hypertension, insulin-dependent and non insulin-dependent diabetes mellitus.

  1993cites this paper
• Lipid abnormalities in chronic uremic patients. Response to treatment with gemfibrozil.

  1993cites this paper
• Reverse Flux Filtration: A New Mode of Therapy Improving the Efficacy of Heparin - Induced Extracorporeal Ldl Precipitation in Hyperlipidemic Hemodialysis Patients

  1993cites this paper
• Hyperlipoproteinaemia in renal failure: pathogenesis and perspectives for intervention.

  1993cites this paper
• Atherogenic lipoproteins: mediators of glomerular injury.

  1993cites this paper
• The effects of various antihypertensive agents on cardiovascular risk factors in patients with renal failure.

  1993cites this paper
• Lipoprotein abnormalities in hypertriglyceridaemic patients on long‐term haemodialysis

  1993cites this paper
• Disturbances of lipid metabolism in children with chronic renal failure

  1993cites this paper
• Association between very-low-density lipoprotein and glomerular injury in obese Zucker rats.

  1993cites this paper
• Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis.

  1993cites this paper
• Vegetarian diets for treating nephrotic syndrome.

  1993cites this paper
• Hyperlipoproteinemia in renal transplant recipients: is there a linkage with chronic vascular rejection?

  1993cites this paper
• Treatment Is Indicated because of the Risk of Accelerated Atherosclerosis

  1993cites this paper
• Treatment of Hypertriglyceridemia in Dialysis Patients Is Expensive and Unproven

  1993cites this paper
• Hyperlipoproteinemia in adults with renal disease.

  1993cites this paper
• Effect of 3-thiadicarboxylic acid on lipid metabolism in experimental nephrosis.

  1993cites this paper